Managing Intellectual PropertyOctober 2013
Robert Schwartz and Dana Lau discuss potential new benefits for innovators and generic drug challengers afforded by the use of inter partes review and supplemental examination.
View Attachment (PDF)
(212) 218-2100 New York
(714) 540-8700 California
(202) 530-1010 Washington DC
© Copyright 2018 Fitzpatrick, Cella, Harper & Scinto. All Rights Reserved. Images are for design purposes only with actors appearing in some photos. Attorney Advertising. Prior results do not guarantee similar outcome.